Journal of the American Chemical Society: New Synthetic Molecules Trigger Immune Response To HIV And Prostate Cancer
New Synthetic Molecules Trigger Immune Response To HIV And Prostate Cancer
"Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases."
An Antibody-Recruiting Small Molecule That Targets HIV gp120
J. Am. Chem. Soc., Articles ASAP
DOI: 10.1021/ja9057647
© 2009 American Chemical Society
J. Am. Chem. Soc., Articles ASAP
DOI: 10.1021/ja9057647
© 2009 American Chemical Society
Chemical Control over Immune Recognition: A Class of Antibody-Recruiting Small Molecules That Target Prostate Cancer
J. Am. Chem. Soc., Articles ASAP. DOI: 10.1021/ja906844e
© 2009 American Chemical Society
Yale University (2009, November 8). New Synthetic Molecules Trigger Immune Response To HIV And Prostate Cancer. ScienceDaily. Retrieved November 9, 2009, from http://www.sciencedaily.co
J. Am. Chem. Soc., Articles ASAP. DOI: 10.1021/ja906844e
© 2009 American Chemical Society
Yale University (2009, November 8). New Synthetic Molecules Trigger Immune Response To HIV And Prostate Cancer. ScienceDaily. Retrieved November 9, 2009, from http://www.sciencedaily.co